Cargando…
Effects of Switching to Aflibercept in Treatment Resistant Macular Edema Secondary to Retinal Vein Occlusion
The aim of this study was to examine 12-month outcomes of eyes switched from intravitreal ranibizumab or bevacizumab to aflibercept for cystoid macular edema due to retinal vein occlusion (RVO). DESIGN: Retrospective, observation, case series. METHODS: A retrospective study was performed assessing e...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004466/ https://www.ncbi.nlm.nih.gov/pubmed/31990746 http://dx.doi.org/10.1097/01.APO.0000617924.11529.88 |